Medicare Enrolled
Dr. Stephen Donahue, MD
Neurology · Savannah, GA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Donahue from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Donahue?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Donahue
Dr. Stephen Donahue is a neurology specialist in Savannah, GA, with 16 years of NPI registration. Based on federal Medicare data, Dr. Donahue performed 55,142 Medicare services across 1,902 unique beneficiaries.
Between the years covered by Open Payments, Dr. Donahue received a total of $24,232 from 94 pharmaceutical and/or device companies across 1680 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Donahue is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 16 years in practice
▲ Top 0% volume in GA
$24,232 industry payments
Medicare Practice Summary
Medicare Utilization ↗55,142
Medicare services
Top 0% in GA for neurology
1,902
Unique beneficiaries
$10
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~3,446 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection (Xeomin), per unit An injection of incobotulinumtoxin A, a botulinum toxin type A product, administered in a quantity of one unit. |
18,300 | $4 | $12 |
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
17,785 | $5 | $10 |
| Injection, eptinezumab-jjmr, 1 mg | 14,500 | $13 | $52 |
| MRI contrast dye injection (gadobutrol) | 2,145 | $0 | $8 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
854 | $83 | $475 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
323 | $55 | $250 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
194 | $116 | $482 |
| Limited needle EMG of arm or leg muscles A test that measures the electrical activity in specific muscles of the arm or leg using a needle electrode. This limited study evaluates muscle function in a targeted area. |
114 | $42 | $167 |
| MRI scan of brain, without contrast A magnetic resonance imaging test of the brain that does not use contrast dye. This procedure creates detailed images of the brain's structure using magnetic fields and radio waves. |
96 | $91 | $1,250 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
94 | $45 | $210 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
82 | $0 | $10 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
75 | $44 | $123 |
| Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | 74 | $51 | $211 |
| New patient office visit, complex (60-74 min) | 74 | $124 | $608 |
| Bilateral facial and neck nerve muscle paralysis injection Injection of a chemical agent to paralyze muscles in the face and neck on both sides. |
71 | $111 | $441 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
47 | $66 | $350 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
40 | $11 | $68 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
40 | $38 | $126 |
| Nerve conduction studies, 7-8 tests A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles. |
37 | $127 | $572 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
26 | $89 | $600 |
| Nerve conduction studies, 5-6 tests A series of 5 to 6 tests that measure how well nerves send electrical signals. The procedure evaluates nerve function and helps identify damage or dysfunction. |
25 | $91 | $579 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
25 | $128 | $525 |
| Injection of anesthetic or steroid into upper neck and back of head nerve An injection of an anesthetic agent and/or steroid into a nerve located in the upper neck and back of the head. |
23 | $61 | $298 |
| MRI of brain with and without contrast An MRI scan of the brain using contrast dye both before and after administration to provide detailed images of brain structures. |
21 | $121 | $1,424 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
21 | $77 | $314 |
| Nerve conduction study, 3-4 tests A diagnostic test that measures how well nerves send electrical signals. It involves performing 3 to 4 separate nerve conduction studies to evaluate nerve function. |
17 | $77 | $364 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
13 | $271 | $1,016 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
13 | $147 | $684 |
| Home health plan of care certification Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians. |
13 | $39 | $156 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.4% high complexity
96.4% medium
3.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$24,232
Total received (2018-2024)
Avg $3,462/year across 7 years
Top 14% in GA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
94
Companies
1,680
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$24,117 (99.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$115 (0.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,183
2023
$4,374
2022
$3,421
2021
$2,933
2020
$2,701
2019
$3,777
2018
$2,844
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$498
UCB, Inc.
$357
EMD Serono, Inc.
$289
PFIZER INC.
$251
Lundbeck LLC
$231
Mallinckrodt Hospital Products Inc.
$228
Biogen, Inc.
$191
Novartis Pharmaceuticals Corporation
$176
Eisai Inc.
$139
SK Life Science, Inc.
$129
Alexion Pharmaceuticals, Inc.
$114
Neurelis, Inc.
$97
JAZZ PHARMACEUTICALS INC.
$95
Genentech USA, Inc.
$91
Takeda Pharmaceuticals U.S.A., Inc.
$82
Sumitomo Pharma America, Inc.
$73
ACADIA Pharmaceuticals Inc
$69
Ipsen Biopharmaceuticals, Inc
$61
TG Therapeutics, Inc.
$60
Averitas Pharma Inc.
$59
Octapharma USA, Inc.
$59
CATALYST PHARMACEUTICALS, INC.
$58
Celgene Corporation
$55
AstraZeneca Pharmaceuticals LP
$52
Neurocrine Biosciences, Inc.
$49
CSL Behring
$48
ARGENX US, INC.
$47
Grifols USA, LLC
$45
LivaNova USA, Inc.
$45
Amgen Inc.
$45
SCILEX PHARMACEUTICALS INC.
$44
Teva Pharmaceuticals USA, Inc.
$42
DePuy Synthes Sales Inc.
$32
ANI Pharmaceuticals, Inc.
$30
Kyowa Kirin, Inc.
$30
Sandoz Inc.
$28
HARMONY BIOSCIENCES LLC
$24
Alnylam Pharmaceuticals Inc.
$21
MITSUBISHI TANABE PHARMA AMERICA, INC.
$21
Merz Pharmaceuticals, LLC
$19
Otsuka America Pharmaceutical, Inc.
$19
BANNER LIFE SCIENCES, LLC
$19
Lilly USA, LLC
$16
Boston Scientific Corporation
$16
Marinus Pharmaceuticals, Inc.
$16
InSightec,Inc
$14
Top 3 companies account for 27.4% of 2024 payments
All-time payments by company (2018-2024) ›
EMD Serono, Inc.
$2,553
Novartis Pharmaceuticals Corporation
$1,411
Biogen, Inc.
$1,389
UCB, Inc.
$1,182
Teva Pharmaceuticals USA, Inc.
$1,101
ABBVIE INC.
$991
AbbVie Inc.
$890
Mallinckrodt Hospital Products Inc.
$857
Sunovion Pharmaceuticals Inc.
$800
Amgen Inc.
$719
Allergan, Inc.
$671
Alexion Pharmaceuticals, Inc.
$669
PFIZER INC.
$635
Lundbeck LLC
$630
Genentech USA, Inc.
$528
SK Life Science, Inc.
$520
Neurelis, Inc.
$421
JAZZ PHARMACEUTICALS INC.
$421
Ipsen Biopharmaceuticals, Inc
$399
Eisai Inc.
$369
CSL Behring
$350
Allergan Inc.
$349
Greenwich Biosciences, Inc.
$268
Mitsubishi Tanabe Pharma America, Inc.
$256
Avanir Pharmaceuticals, Inc.
$231
Celgene Corporation
$227
TG THERAPEUTICS, INC.
$218
GENZYME CORPORATION
$205
ARGENX US, INC.
$197
Neurocrine Biosciences, Inc.
$195
Supernus Pharmaceuticals, Inc.
$193
Sumitomo Pharma America, Inc.
$187
Biohaven Pharmaceutical Holding Company Ltd.
$183
Octapharma USA, Inc.
$174
Acorda Therapeutics, Inc
$172
Mallinckrodt LLC
$169
Mallinckrodt Enterprises LLC
$161
EISAI INC.
$150
ACADIA Pharmaceuticals Inc
$146
Merz North America, Inc.
$143
Lilly USA, LLC
$142
Harmony Biosciences LLC
$122
Boehringer Ingelheim Pharmaceuticals, Inc.
$120
Kyowa Kirin, Inc.
$119
Merz Pharmaceuticals, LLC
$119
Takeda Pharmaceuticals U.S.A., Inc.
$114
Biohaven Pharmaceuticals, Inc.
$112
E.R. Squibb & Sons, L.L.C.
$111
LivaNova USA, Inc.
$96
MITSUBISHI TANABE PHARMA AMERICA, INC.
$89
Otsuka America Pharmaceutical, Inc.
$84
Upsher-Smith Laboratories LLC
$83
Bausch Health US, LLC
$79
Janssen Pharmaceuticals, Inc
$76
CATALYST PHARMACEUTICALS, INC.
$72
Horizon Therapeutics plc
$70
Grifols USA, LLC
$70
AQUESTIVE THERAPEUTICS, INC.
$69
HARMONY BIOSCIENCES LLC
$64
TG Therapeutics, Inc.
$60
Adamas Pharmaceuticals, Inc.
$60
Averitas Pharma Inc.
$59
AstraZeneca Pharmaceuticals LP
$52
ANI Pharmaceuticals, Inc.
$50
Promius Pharma LLC
$49
HOSPIRA, INC.
$46
SCILEX PHARMACEUTICALS INC.
$44
BANNER LIFE SCIENCES, LLC
$40
Sarepta Therapeutics, Inc.
$39
Alnylam Pharmaceuticals Inc.
$39
Scilex Pharmaceuticals Inc.
$35
Akcea Therapeutics, Inc.
$34
Jazz Pharmaceuticals Inc.
$33
Marinus Pharmaceuticals, Inc.
$33
DePuy Synthes Sales Inc.
$32
IMPEL PHARMACEUTICALS INC.
$30
Boston Scientific Corporation
$29
Sandoz Inc.
$28
BOSTON SCIENTIFIC CORPORATION
$28
US WorldMeds, LLC
$26
Organogenesis Inc.
$24
Amylyx Pharmaceuticals, Inc.
$23
Banner Life Sciences, LLC
$21
Azurity Pharmaceuticals, Inc.
$20
MERZ NORTH AMERICA, INC.
$20
Avion Pharmaceuticals
$20
GRT US Holding, Inc.
$20
AbbVie, Inc.
$18
Zogenix Inc.
$15
InSightec,Inc
$14
Catalyst Pharmaceuticals, Inc.
$13
Medtronic, Inc.
$12
Neos Therapeutics, LP
$12
Medtronic Vascular, Inc.
$12
Top 3 companies account for 22.1% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMVUTTRA · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Adzenys XR-ODT · Aimovig · Austedo XR · BAFIERTAM · BOTOX · BOTOX THERAPEUTIC · BRIUMVI · Briviact · COPAXONE · DAYBUE · DUOPA · DYSPORT · Dhivy · Duopa · Dysport · ELYXYB - CELECOXIB · EMGALITY · EPIDIOLEX · Enspryng · Epidiolex · Eprontia · Evrysdi · Exablate · Exondys 51 · FIRDAPSE · FYCOMPA · Fintepla · Fycompa · GENERAL PAIN MANAGEMENT · GILENYA · GOCOVRI · Gamunex-C · General - Pain Management · HYQVIA · Hizentra · INBRIJA · INGREZZA · JARDIANCE · KESIMPTA · KYNMOBI · LEMTRADA · LINQ II · LYRICA · Leqembi · MAVENCLAD · MAYZENT · MIGRANAL · Mavenclad · NA · NAMZARIC · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Nourianz · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONFI · ONPATTRO · OXTELLAR XR · Ocrevus · Ongentys · PANZYGA · PLEGRIDY · POMPE - DISEASE · PURIFIED CORTROPHIN GEL · Ponvory · Puraply · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · QUTENZA · Qutenza · RADICAVA · RELYVRIO · REXULTI · Radicava · Rebif · Reveal LINQ · Rystiggo · SKYCLARYS · SOLIRIS · SPINRAZA · SUNOSI · SYMPAZAN · Skyclarys · Soliris · TECFIDERA · TEGSEDI · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VIGADRONE (vigabatrin) for Oral Solution · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VUMERITY · VYALEV · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · WAINUA · WAKIX · WATCHMAN · WATCHMAN FLX · Wakix · XEOMIN · XYREM · XYWAV · Xadago · Xeomin · Xyrem · ZEMBRACE SYMTOUCH · ZEPOSIA · ZTALMY · ZTLido · Zembrace
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Neurologists within 10 mi
26
Per 100K population
8.7
County median income
$69,575
Nearest hospital
COASTAL HARBOR TREATMENT CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Donahue is a mixed practice specialist, with above-average Medicare volume (top 0% in GA), with low-engagement industry engagement in the top 14% of GA peers, with 16 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Donahue experienced with botox injection (xeomin), per unit?
Based on Medicare claims data, Dr. Donahue performed 18,300 botox injection (xeomin), per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Donahue receive payments from pharmaceutical companies?
Yes. Dr. Donahue received a total of $24,232 from 94 companies across 1,680 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Donahue's costs compare to other neurologists in Savannah?
Dr. Donahue's average Medicare payment per service is $10. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Donahue) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Savannah
Browse neurologists in Savannah ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in GA
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in GA
Which GA neurologists receive the most from drug and device companies.
By company
EMD Serono, Inc. Payments to Doctors
See all physicians who received payments from EMD Serono, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Biogen, Inc. Payments to Doctors
See all physicians who received payments from Biogen, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology